Sign in

CIK 0001070494

  • Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061376651
Phone
+1 858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale EVP & General Counsel sold 1,054 shares at $20.33 ($21,428)
  2. 4 Open-market sale President sold 4,230 shares at $20.33 ($85,996)
  3. 4 Open-market sale CEO sold 7,850 shares at $20.33 ($159,591)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale EVP and CFO sold 2,051 shares at $50.61 ($103,801)
  10. 4 Open-market sale CEO sold 14,195 shares at $50.61 ($718,409)
  11. 4 Open-market sale President sold 8,429 shares at $50.61 ($426,592)
  12. 4 Open-market sale EVP & General Counsel sold 2,107 shares at $50.61 ($106,635)
  13. 4 Open-market sale President sold 700 shares at $55.01 ($38,507)
  14. 4 Open-market sale EVP and CCO sold 1,120 shares at $53.34 ($59,741)
  15. 4 Open-market sale EVP & General Counsel sold 678 shares at $53.34 ($36,165)
  16. 4 Open-market sale EVP and CFO sold 1,016 shares at $53.34 ($54,193)
  17. 4 Open-market sale President sold 93,077 shares at an average $55.12 ($5,130,031)
  18. 4 Open-market sale CEO sold 3,484 shares at $53.34 ($185,837)
  19. 4 Open-market sale President sold 2,728 shares at $53.50 ($145,948)
  20. 4 Open-market sale EVP & General Counsel sold 8,750 shares at $45.10 ($394,636)

Page 11 of 35 · 686 filings